96. クローン病
[臨床試験数:2,209,薬物数:1,276(DrugBank:240),標的遺伝子数:166,標的パスウェイ数:210

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
7 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2010-019996-32-BG
(EUCTR)
27/04/201124/02/2011A clinical trial to evaluate whether Neovacs' TNFa-Kinoid is effective andsafe for treating adult subjects with moderate to severe Crohn's DiseaseA phase II, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety and immunogenicity of Neovacs’TNFa-Kinoid in adult subjects with Crohn’s Disease - TNF-K-005 Moderate to severe Crohn's Disease
MedDRA version: 14.0;Level: PT;Classification code 10011401;Term: Crohn's disease;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: TNFa-Kinoid
Product Code: TNF-K
INN or Proposed INN: Not assigned yet
Neovacs SANULLNot RecruitingFemale: yes
Male: yes
132Phase 2France;Hungary;Czech Republic;Belgium;Croatia;Romania;Bulgaria;Netherlands;Germany
2EUCTR2010-019996-32-DE
(EUCTR)
31/03/201122/11/2010A clinical trial to evaluate whether Neovacs' TNFa-Kinoid is effective andsafe for treating adult subjects with moderate to severe Crohn's DiseaseA phase II, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety and immunogenicity of Neovacs’TNFa-Kinoid in adult subjects with Crohn’s Disease Crohn’s Disease
MedDRA version: 16.0;Level: PT;Classification code 10011401;Term: Crohn's disease;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: TNF-Kinoid
Product Code: TNF-K
INN or Proposed INN: Not assigned yet
Neovacs SANULLNot RecruitingFemale: yes
Male: yes
132Phase 2France;Hungary;Czech Republic;Belgium;Croatia;Romania;Bulgaria;Netherlands;Germany
3EUCTR2010-019996-32-HU
(EUCTR)
18/03/201131/01/2011A phase II, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety and immunogenicity of Neovacs’TNFa-Kinoid in adult subjects with Crohn’s DiseaseA phase II, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety and immunogenicity of Neovacs’TNFa-Kinoid in adult subjects with Crohn’s Disease Crohn’s Disease
MedDRA version: 12.1;Level: PT;Classification code 10011401;Term: Crohn's disease
Product Name: TNFa-Kinoid
Product Code: TNF-K
INN or Proposed INN: Not assigned yet
Neovacs SANULLNot RecruitingFemale: yes
Male: yes
132Phase 2Hungary;Belgium;Bulgaria;Netherlands;Germany
4EUCTR2010-019996-32-CZ
(EUCTR)
11/02/201126/11/2010A phase II, randomized, double-blind, placebo-controlled study toevaluate the clinical efficacy, safety and immunogenicity ofNeovacs'TNFa-Kinoid in adult subjects with Crohn's DiseaseA phase II, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety and immunogenicity of Neovacs’TNFa-Kinoid in adult subjects with Crohn’s Disease Crohn’s Disease
MedDRA version: 14.1;Level: PT;Classification code 10011401;Term: Crohn's disease;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: TNFa-Kinoid
Product Code: TNF-K
INN or Proposed INN: Not assigned yet
Neovacs SANULLNot RecruitingFemale: yes
Male: yes
132Phase 2France;Hungary;Czech Republic;Belgium;Romania;Croatia;Bulgaria;Netherlands;Germany
5NCT01291810
(ClinicalTrials.gov)
February 201117/12/2010Clinical Efficacy of TNFa Kinoid in Crohn's Disease PatientsA Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy, Safety and Immunogenicity of Neovacs' TNFa-Kinoid in Adult Subjects With Crohn's DiseaseCrohn's DiseaseBiological: TNF Kinoid;Biological: WFINeovacsNULLCompleted18 Years65 YearsBoth66Phase 2Belgium;Bulgaria;Croatia;Czech Republic;France;Germany;Hungary;Netherlands;Romania
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT00808262
(ClinicalTrials.gov)
October 200812/12/2008Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's DiseaseA Phase I/II, Open-label, Escalating Dose, Optimal Two-stage, Study of TNFa-Kinoid (TNF- K) Immunization in Crohn's Disease PatientsCrohn's DiseaseBiological: TNFa KinoidNeovacsNULLCompleted18 Years65 YearsBoth21Phase 1;Phase 2South Africa;Switzerland
7EUCTR2010-019996-32-NL
(EUCTR)
27/07/2011A clinical trial to evaluate whether Neovacs' TNFa-Kinoid is effective and safe for treating adult subjects with moderate to severe Crohn's DiseaseA phase II, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety and immunogenicity of Neovacs’ TNFa-Kinoid in adult subjects with Crohn’s Disease - TNF-K-005 Moderate to severe Crohn’s Disease
MedDRA version: 14.1;Level: PT;Classification code 10011401;Term: Crohn's disease;System Organ Class: 10017947 - Gastrointestinal disorders;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: TNF-Kinoid
Product Code: TNF-K
INN or Proposed INN: Not assigned yet
Neovacs SANULLNot RecruitingFemale: yes
Male: yes
132Phase 2France;Hungary;Czech Republic;Belgium;Croatia;Romania;Bulgaria;Germany;Netherlands